
The Pharm Exec Podcast goes beyond the pages of the Pharmaceutical Executive print magazine and PharmExec.com to bring the latest commercial insights to the C-suite through in-depth interviews. Podcast episodes examine current trends, key conferences, and critical topics in the industry.
| Publishes | Daily | Episodes | 352 | Founded | 8 years ago |
|---|---|---|---|---|---|
| Number of Listeners | Categories | Life SciencesScience | |||

In today’s Pharmaceutical Executive Daily, the FDA extends its priority review of a subcutaneous formulation of Leqembi, industry analysts examine how upcoming GLP-1 patent expirations could reshape the drug delivery device market, and experts discus... more
In today's Pharmaceutical Executive Daily, Angelini Pharma announces a $4.1 billion agreement to acquire Catalyst Pharmaceuticals, Incyte presents 24-week results from the Phase III TRuE-AD4 trial of Opzelura, and Pharmaceutical Executive speaks with... more
Natalie de Graaf, from the API Innovation Center, discusses a recent whitepaper detailing areas where the generic drugs pipeline is under stress.
In today's Pharmaceutical Executive Daily, Bayer agrees to acquire Perfuse Therapeutics for up to $2.45 billion and Madrigal obtains an exclusive global license for a precision siRNA therapy targeting a key genetic driver of MASH, Zentalis Pharmaceut... more
People also subscribe to these shows.





A value-packed podcast in a tidy package! Every episode brings excellent perspectives from knowledgeable guests, with actionable leadership tips as the cherry on top. Don't miss it!
Hi! I really enjoy this podcast. You discuss great topics and interview knowledgeable people. Improving the sound quality would really make the listening experience much more enjoyable. There tends to be a muffled and unclear effect to the sound. Thanks!
Key themes from listener reviews, highlighting what works and what could be improved about the show.
How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.
Apple Podcasts | #97 | |
Apple Podcasts | #69 | |
Apple Podcasts | #96 | |
Apple Podcasts | #42 | |
Apple Podcasts | #75 | |
Apple Podcasts | #79 |
Recent interactions between the hosts and their guests.
Listeners, social reach, demographics and more for this podcast.
| Listeners per Episode | |
|---|---|
| Gender Skew | |
| Location | |
| Interests | |
| Professions | |
| Age Range | |
| Household Income | |
| Social Media Reach |
A brisk, business-focused show that treats pharma and life sciences topics through executive-level conversations. Episodes emphasize market moves, regulatory milestones, pricing and GTN dynamics, and the operational realities of commercializing advanced therapies. Listeners can expect hard-hitting analyses of deals, policy shifts, and supply-chain considerations, with actionable takeaways for strategy, partnerships, and investment. A notable strength is bringing operator-level perspectives on scaling complex therapies and navigating global manufacturing and distribution, making it useful for leaders, investors, and partners evaluating opportunities in biotech and pharma.
Rephonic provides a wide range of podcast stats for Pharmaceutical Executive. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Pharmaceutical Executive and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.
Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for Pharmaceutical Executive, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.
Rephonic provides comprehensive predictive audience data for Pharmaceutical Executive, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.
To see how many followers or subscribers Pharmaceutical Executive has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.
These podcasts share a similar audience with Pharmaceutical Executive:
1. The Readout Loud
2. BioCentury This Week
3. In Good Company with Nicolai Tangen
4. Bloomberg Intelligence
5. Bloomberg Surveillance
Pharmaceutical Executive launched 8 years ago and published 352 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.
Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.
Rephonic pulls ratings and reviews for Pharmaceutical Executive from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.
View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.
Rephonic provides full transcripts for episodes of Pharmaceutical Executive. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.
Recent guests on Pharmaceutical Executive include:
1. Natalie de Graaf
2. Peter Harbin
3. Jeff Golfman
4. Maher Masoud
5. Michael Grosberg
6. Jesse Mendelson
7. Deepak Prakash
8. Matt Holms
To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.